Literature DB >> 3116043

Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells.

B S Knudsen1, P C Harpel, R L Nachman.   

Abstract

The extracellular matrix secreted by cultured bovine smooth muscle cells (BSMC) contains an endothelial type plasminogen activator (PA) inhibitor. When PA is incubated with the matrix, a high molecular weight complex containing a truncated PA inhibitor is released into the supernatant. The inhibitor also dissociates from the matrix by treatment with glycine, pH 2.7, in its intact, functionally active, 45-kD form, whereas treatment of the matrix with thrombin results in the release of a cleaved, inactive, 41 kD PA inhibitor. Bowes melanoma cells but not smooth muscle cells cultured on BSMC matrices decrease available matrix associated PA inhibitor. PA inhibitor incorporated into the extracellular matrix may serve an important role in the regulation of plasminogen activator mediated matrix degradation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3116043      PMCID: PMC442350          DOI: 10.1172/JCI113164

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue culture.

Authors:  L Holmberg; I Lecander; B Persson; B Astedt
Journal:  Biochim Biophys Acta       Date:  1978-11-15

2.  Synthesis of a fibrinolytic activator and inhibitor by endothelial cells.

Authors:  D J Loskutoff; T E Edgington
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

3.  An anticatalytic monoclonal antibody to avian plasminogen activator: its effect on behavior of RSV-transformed chick fibroblasts.

Authors:  L M Sullivan; J P Quigley
Journal:  Cell       Date:  1986-06-20       Impact factor: 41.582

4.  Partial purification and properties of urokinase inhibitor from human placenta.

Authors:  T Kawano; K Morimoto; Y Uemura
Journal:  J Biochem       Date:  1970-03       Impact factor: 3.387

5.  Plasminogen activator synthesis by cultured human embryonic lung cells: characterization of the suppressive effect of corticosteroids.

Authors:  D B Rifkin
Journal:  J Cell Physiol       Date:  1978-12       Impact factor: 6.384

6.  Production of a fibrinolytic inhibitor by cultured endothelial cells derived from human umbilical vein.

Authors:  A M Dosne; E Dupuy; E Bodevin
Journal:  Thromb Res       Date:  1978-03       Impact factor: 3.944

7.  Phorbol ester-induced morphological changes in transformed chick fibroblasts: evidence for direct catalytic involvement of plasminogen activator.

Authors:  J P Quigley
Journal:  Cell       Date:  1979-05       Impact factor: 41.582

8.  Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells.

Authors:  J B Baker; D A Low; R L Simmer; D D Cunningham
Journal:  Cell       Date:  1980-08       Impact factor: 41.582

9.  Inhibition of experimental blood-borne lung metastasis by protease inhibitors.

Authors:  D Saito; M Sawamura; K Umezawa; Y Kanai; C Furihata; T Matsushima; T Sugimura
Journal:  Cancer Res       Date:  1980-07       Impact factor: 12.701

10.  Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator.

Authors:  Z Werb; C L Mainardi; C A Vater; E D Harris
Journal:  N Engl J Med       Date:  1977-05-05       Impact factor: 91.245

View more
  27 in total

1.  Transforming growth factor-ßs as modulators of pericellular proteolytic events.

Authors:  J Keski-Oja; J Lohi; M Laiho
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

2.  Rapid neural regulation of muscle urokinase-like plasminogen activator as defined by nerve crush.

Authors:  D Hantaï; J S Rao; B W Festoff
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

3.  Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy?

Authors:  D J Buttle; H Bramwell; A P Hollander
Journal:  Clin Mol Pathol       Date:  1995-08

4.  Impaired abdominal wall development and deficient wound healing in mice lacking aortic carboxypeptidase-like protein.

Authors:  M D Layne; S F Yet; K Maemura; C M Hsieh; M Bernfield; M A Perrella; M E Lee
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

5.  Urokinase-dependent adhesion loss and shape change after cyclic adenosine monophosphate elevation in cultured rat mesangial cells.

Authors:  W F Glass; R A Radnik; J A Garoni; J I Kreisberg
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

6.  Plasminogen activator inhibitor-1 deposition in the extracellular matrix of cultured human mesangial cells.

Authors:  J Hagège; M N Peraldi; E Rondeau; C Adida; F Delarue; R Medcalf; W D Schleuning; J D Sraer
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

7.  Transcriptional regulation of plasminogen activator inhibitor type-1 mRNA in Hep G2 cells by epidermal growth factor.

Authors:  W E Hopkins; D R Westerhausen; B E Sobel; J J Billadello
Journal:  Nucleic Acids Res       Date:  1991-01-11       Impact factor: 16.971

8.  A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis.

Authors:  Yufeng Huang; Masashi Haraguchi; Daniel A Lawrence; Wayne A Border; Ling Yu; Nancy A Noble
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

9.  Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts.

Authors:  E Gazzerro; V Gangji; E Canalis
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

10.  von Willebrand factor mediates platelet adhesion to virally infected endothelial cells.

Authors:  O R Etingin; R L Silverstein; D P Hajjar
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.